Localization of human BRCA1 and its loss in high-grade, non-inherited breast carcinomas

Nature Genetics

Volumn 21, Issue 2, 1999, Pages 236-240

  Wilson, Cindy A ^a   Ramos, Lillian ^a   Villaseñor, Maria R ^a   Anders, Karl H ^b   Press, Michael F ^c   Clarke, Kathy ^a   Karlan, Beth ^a   Chen, Jun Jie ^d   Scully, Ralph ^d   Livingston, David ^d   Zuch, Robert H ^b   Kanter, Michael H ^b   Cohen, Sylvan ^b   Calzone, Frank J ^e   Slamon, Dennis J ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b Southern California Permanente Medical Group   (United States)

^c UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^d DANA FARBER CANCER INSTITUTE   (United States)

^e AMGEN INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL CELL; ARTICLE; BREAST CARCINOMA; CANCER GRADING; CELLULAR DISTRIBUTION; GENE MUTATION; HUMAN; HUMAN TISSUE; NONHUMAN; PRIORITY JOURNAL; PROTEIN LOCALIZATION; TUMOR SUPPRESSOR GENE;

ANTIBODIES; ANTIBODY SPECIFICITY; BRCA1 PROTEIN; BREAST NEOPLASMS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; SUBCELLULAR FRACTIONS; TUMOR CELLS, CULTURED;

EID: 0032953384     PISSN: 10614036     EISSN: None     Source Type: Journal    
DOI: 10.1038/6029     Document Type: Article

References (27)

1. Miki, Y. et al. A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science 266, 66-71 (1994).
2. Castilla, L.H. et al. Mutations in the BRCA1 gene in families with early-onset breast and ovarian cancer. Nature Genet. 8, 387-391 (1994).
3. Friedman, L.S. et al. Confirmation of BRCA1 by analysis of germline mutations linked to breast and ovarian cancer in ten families. Nature Genet. 8, 399-404 (1994).
4. Shattuck-Eidens, D. et al. A collaborative survey of 80 mutations in the BRCA1 breast and ovarian cancer susceptibility gene. Implications for presymptomatic testing and screening. J. Am. Med. Assoc. 273, 535-541 (1995).
5. Couch, F.J., Weber, B.L. & Core, B.C.I. Mutations and polymorphisms in the familial early-onset breast cancer (BRCA1) gene. Hum. Mutat. 8, 8-18 (1996).
6. Futreal, P.A. et al. BRCA1 mutations in primary breast and ovarian carcinomas. Science 266, 120-122 (1994).
7. Merajver, S.D. et al. Somatic mutations in the BRCA1 gene in sporadic ovarian tumours. Nature Genet. 9, 439-443 (1995).
8. Hosking, L. et al. A somatic BRCA1 mutation in an ovarian tumour. Nature Genet. 9, 343-344 (1995).
9. Thompson, M.E., Jensen, R.A., Obermiller, P.S., Page, D.L. & Holt, J.T. Decreased expression of BRCA1 accelerates growth and is often present during sporadic breast cancer progression. Nature Genet. 9, 444-450 (1995).
10. Chen, Y. et al. Aberrant subcellular localization of BRCA1 in breast cancer. Science 270, 789-791 (1995).
11. Scully, R. et al. Location of BRCA1 in human breast and ovarian cancer cells. Science 272, 123-126 (1996).
12. Thakur, S. et al. Localization of BRCA1 and a splice variant identifies the nuclear localization signal. Mol. Cell. Biol. 17, 444-452 (1997).
13. Wilson, C.A. et al. Differential subcellular localization, expression and biological toxicity of BRCA1 and the splice variant BRCA1-A11b. Oncogene 14, 1-16 (1997).
14. Ruffner, H. & Verma, I.M. BRCA1 is a cell cycle-regulated nuclear phosphoprotein. Proc. Natl Acad. Sci. USA 94, 7138-7143 (1997).
15. Thomas, J.E. et al. Subcellular localization and analysis of apparent 180-kDa and 220-kDa proteins of the breast cancer susceptibility gene, BRCA1. J. Siam. Chem. 271, 28630-28635 (1996).
16. Jensen, R.A. et al. BRCA1 is secreted and exhibits properties of a granin. Nature Genet. 12, 303-308 (1996).
17. Coene, E., Van, O.P., Willems, K., van, E.J. & De, P.C. BRCA1 is localized in cytoplasmic tube-like invaginations in the nucleus. Nature Genet. 16, 122-124 (1997).
18. Chen, Y. et al. BRCA1 is a 220-kDa nuclear phosphoprotein that is expressed and phosphorylated in a cell cycle-dependent manner. Cancer Res. 56, 3168-3172 (1996).
19. Scully, R. et al. Dynamic changes of BRCA1 subnuclear location and phosphorylation state are initiated by DNA damage. Cell 90, 425-435 (1997).
20. Scully, R. et al. Association of BRCA1 with Rad51 in mitotic and meiotic cells. Cell 88, 265-275 (1997).
21. Wilson, C.A. et al. BRCA1 protein products: antibody specificity... Nature Genet. 13, 264-265 (1996).
22. Futreal, P.A. et al. Detection of frequent allelic loss on proximal chromosome 17q in sporadic breast carcinoma using microsatellite length polymorphisms. Cancer Res. 52, 2624-2627 (1992).
23. Schmutzler, R.K. et al. Genomic deletions in the BRCA1, BRCA2 and TP53 regions associate with low expression of the estrogen receptor in sporadic breast carcinoma. Int. J. Cancer 74, 322-325 (1997).
24. Russell, S.E., Hickey, G.I., Lowry, W.S., White, P. & Atkinson, R.J. Allele loss from chromosome 17 in ovarian cancer. Oncogene 5, 1581-1583 (1990).
25. Dobrovic, A. & Simpfendorfer, D. Methylation of the BRCA1 gene in sporadic breast cancer. Cancer Res. 57, 3347-3350 (1997).
26. Mancini, D.N. et al. CpG methylation within the 5′ regulatory region of the BRCA1 gene is tumor specific and includes a putative CREB binding site. Oncogene 16, 1161-1169 (1998).
27. Slamon, D.J. et al. Identification and characterization of the protein encoded by the human N-myc oncogene. Science 232, 768-772 (1986).